Role of cardiac natriuretic peptide testing in heart failure

Clinical Chemistry

Volumn 48, Issue 7, 2002, Pages 977-978

  Mair, Johannes ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036089912     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.7.977     Document Type: Editorial

References (11)

1. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats
2. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure
3. Assay of brain natriuretic peptide (BNP) in human plasma: Evidence for high molecular weight BNP as a major plasma component in heart failure
4. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme
5. Quantification of pro-B-type natriuretic peptide and its products in human plasma using an analysis independent of precursor processing
6. Processing-independent radioimmunoanalysis: A general analytical principle applied to progastrin and its products
7. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: The need for a new generation of immunoassay methods
8. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit
9. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting
10. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
11. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations